CN Stock MarketDetailed Quotes

603102 Weihai Baihe Biology Technological

Watchlist

38.40
+0.76+2.02%

Market Closed Dec 3 15:00 CST

2.46BMarket Cap15.65P/E (TTM)

Weihai Baihe Biology Technological Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

0.24%1.08B

0.67%1.07B

4.47%1.09B

3.27%1.14B

3.92%1.08B

6.58%1.06B

2.53%1.04B

165.51%1.1B

164.02%1.04B

144.30%994.2M

Notes receivable and accounts receivable

44.06%56.26M

33.71%54.1M

-20.06%48.97M

9.18%45.17M

-18.61%39.05M

6.36%40.46M

87.82%61.26M

30.21%41.38M

41.27%47.99M

25.66%38.04M

-Notes receivable

-1.37%2.97M

-52.63%1.7M

-43.19%8.32M

10.27%9.41M

-16.33%3.01M

20.63%3.58M

227.35%14.65M

119.06%8.53M

--3.6M

--2.97M

-Accounts receivable

47.86%53.29M

42.10%52.4M

-12.78%40.65M

8.90%35.77M

-18.80%36.04M

5.15%36.87M

65.63%46.61M

17.79%32.84M

30.67%44.38M

15.84%35.07M

Other receivables (including interest and dividends)

36.56%1.34M

42.82%1.32M

-87.43%1.15M

-78.52%1.25M

33.42%979.82K

29.96%921.65K

1,262.95%9.17M

292.95%5.83M

146.54%734.37K

162.69%709.18K

-Other receivable

----

42.82%1.32M

----

29.96%921.65K

----

292.95%5.83M

----

162.69%709.18K

Advance payment

130.66%17.72M

187.48%23.63M

55.55%16.87M

16.78%7.32M

1.40%7.68M

2.24%8.22M

190.98%10.85M

106.57%6.27M

117.15%7.58M

273.77%8.04M

Inventories

-17.17%102.57M

-18.08%112.27M

-28.72%105.72M

-15.28%124.61M

6.92%123.83M

7.86%137.05M

32.79%148.31M

31.67%147.08M

16.63%115.81M

54.89%127.06M

Receivable financing

23.14%7.55M

-25.94%6.95M

-31.76%6.69M

56.45%8.87M

-26.05%6.13M

24.62%9.38M

3.29%9.81M

98.46%5.67M

76.94%8.29M

31.21%7.53M

Other current assets

-2.72%52.44M

-0.62%52.61M

-1.39%51.4M

104.88%3.17M

137.73%53.9M

155.80%52.94M

6,060.48%52.13M

-30.35%1.55M

1,297.85%22.67M

2,988.87%20.7M

Total current assets

0.68%1.32B

0.69%1.32B

-1.05%1.32B

1.42%1.33B

5.58%1.31B

9.39%1.31B

13.44%1.34B

130.49%1.31B

131.29%1.24B

126.53%1.2B

Non Current assets

Investment real estate

-40.71%456.2K

-40.17%466.45K

184.43%476.71K

185.24%486.96K

342.60%769.42K

340.60%779.67K

-6.93%167.6K

-6.81%170.72K

-6.70%173.84K

-6.59%176.96K

Fixed assets

----

-0.46%321.7M

----

13.69%323.2M

----

0.40%295.14M

----

63.39%284.27M

Constru in process

----

469.53%38.12M

----

-56.42%6.69M

----

17.23%17.07M

----

-64.08%15.36M

Intangible assets

7.59%48.45M

7.51%48.76M

72.63%46.4M

64.77%44.74M

64.31%45.03M

64.11%45.36M

-3.27%26.88M

21.14%27.15M

20.70%27.41M

21.36%27.64M

Goodwill

0.00%517.84K

Deferred tax assets

-9.95%2.21M

-7.78%2.21M

-13.04%2.06M

4.46%1.97M

28.39%2.46M

40.16%2.4M

32.76%2.36M

15.19%1.89M

5.19%1.91M

-15.26%1.71M

Usufruct assets

-6.52%2.58M

-4.40%2.92M

-17.81%2.76M

-16.11%3.06M

-23.84%2.76M

10.05%3.06M

9.24%3.35M

8.58%3.65M

--3.62M

--2.78M

Other non current assets

-23.26%18.51M

-6.81%17.04M

72.29%17.13M

-0.01%8.95M

94.85%24.13M

6.24%18.29M

-13.22%9.94M

-25.52%8.95M

38.82%12.38M

-35.54%17.21M

Total non current assets

9.81%444.01M

7.86%431.74M

18.14%420.36M

15.68%410.14M

16.02%404.34M

14.48%400.29M

1.20%355.83M

1.68%354.54M

10.39%348.51M

30.02%349.66M

Total assets

2.84%1.76B

2.37%1.75B

2.99%1.74B

4.46%1.74B

7.87%1.71B

10.54%1.71B

10.63%1.69B

81.46%1.66B

86.47%1.59B

93.96%1.55B

Liabilities

Current liabilities

Notes payable and accounts payable

5.39%80.79M

6.18%99.4M

-13.30%82.34M

9.52%108.02M

-11.55%76.65M

11.40%93.62M

5.88%94.97M

-1.00%98.63M

39.01%86.66M

26.10%84.04M

-Accounts payable

5.39%80.79M

6.18%99.4M

-13.30%82.34M

9.52%108.02M

-11.55%76.65M

11.40%93.62M

5.88%94.97M

-1.00%98.63M

39.01%86.66M

26.10%84.04M

Contract liabilities

-37.76%33.9M

-36.48%39.74M

-27.20%41.7M

-34.25%44.87M

31.81%54.48M

48.50%62.56M

74.90%57.28M

66.74%68.25M

-15.62%41.33M

9.09%42.13M

Advance receipts

-8.86%445.32K

-8.67%456.15K

-0.50%466.97K

1.22%477.8K

2.93%488.62K

4.62%499.45K

-2.23%469.34K

-2.22%472.02K

--474.7K

--477.39K

Salaries payable

-12.13%15.38M

-20.08%12.26M

9.64%13.34M

11.60%18.4M

33.02%17.51M

44.61%15.34M

37.52%12.17M

13.93%16.49M

19.27%13.16M

14.04%10.61M

Taxs payable

8.77%6.54M

18.98%9M

58.68%9.55M

-7.93%6.22M

-38.09%6.02M

-6.68%7.56M

432.82%6.02M

430.97%6.76M

90.96%9.72M

19.00%8.1M

Other payable (including interest and dividends)

-1.95%15.36M

-8.02%15.09M

-0.95%15.17M

4.89%16.29M

10.13%15.66M

13.76%16.41M

-16.92%15.32M

11.01%15.53M

8.04%14.22M

5.99%14.42M

-Other payable

----

-8.02%15.09M

----

13.76%16.41M

----

11.01%15.53M

----

5.99%14.42M

Non current liabilities due within one year

202.37%1.78M

212.65%1.91M

181.22%1.79M

212.00%1.95M

-41.72%589.38K

-48.25%612.31K

-45.71%634.98K

-45.13%624.12K

--1.01M

--1.18M

Other current liabilities

-22.30%6.41M

-41.96%5.31M

-27.18%11.48M

-28.76%7.36M

34.56%8.25M

90.64%9.16M

214.93%15.76M

58.01%10.34M

19.27%6.13M

7.27%4.8M

Total current liabilities

-10.59%160.61M

-10.98%183.18M

-13.22%175.84M

-6.21%203.6M

4.01%179.64M

24.13%205.76M

28.64%202.62M

21.65%217.09M

18.50%172.7M

18.86%165.77M

Current liabilities

Deferred tax liabilities

----

--413.75K

--458.34K

----

Long term deferred income

-7.78%17.51M

-17.69%16.36M

-13.97%17.23M

-13.40%18.1M

-12.82%18.99M

-12.22%19.88M

-8.58%20.03M

-2.46%20.9M

-1.97%21.78M

-1.57%22.65M

Lease liabilities

-92.53%113.35K

-89.08%180.48K

----

-42.90%1.52M

-3.34%1.65M

-17.10%1.79M

-16.23%1.95M

--2.66M

--1.71M

Total non current liabilities

-15.75%17.63M

-24.77%16.55M

-21.01%17.23M

-20.78%18.1M

-14.39%20.92M

-9.71%21.99M

-9.35%21.81M

-3.81%22.85M

9.99%24.44M

5.86%24.36M

Total liabilities

-11.13%178.24M

-12.31%199.72M

-13.98%193.07M

-7.60%221.7M

1.73%200.56M

19.79%227.75M

23.60%224.44M

18.66%239.93M

17.37%197.14M

17.02%190.13M

Shareholders equity

Paid-in capital

0.00%64M

33.33%64M

Capital reserve funds

0.00%654.95M

0.01%654.95M

856.73%654.95M

856.64%654.89M

Surplus reserve funds

19.83%101.03M

13.75%101.03M

19.83%101.03M

19.63%84.31M

26.02%88.82M

19.63%84.31M

26.79%70.48M

Retained profit

13.02%801.4M

13.25%767.71M

16.47%767.59M

18.41%732.74M

17.90%709.1M

19.67%677.86M

18.14%659.07M

17.47%618.79M

17.56%601.43M

22.47%566.45M

Less:Treasury stock

--38.09M

--38.86M

--38.25M

----

Shareholders equity without minority interests

4.69%1.58B

4.62%1.55B

5.58%1.55B

6.50%1.51B

8.74%1.51B

9.24%1.48B

8.88%1.47B

99.25%1.42B

103.44%1.39B

113.66%1.36B

Total shareholder equity

4.69%1.58B

4.62%1.55B

5.58%1.55B

6.50%1.51B

8.74%1.51B

9.24%1.48B

8.88%1.47B

99.25%1.42B

103.44%1.39B

113.66%1.36B

Total liabilityies and equity

2.84%1.76B

2.37%1.75B

2.99%1.74B

4.46%1.74B

7.87%1.71B

10.54%1.71B

10.63%1.69B

81.46%1.66B

86.47%1.59B

93.96%1.55B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Rong Cheng Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	0.24%1.08B	0.67%1.07B	4.47%1.09B	3.27%1.14B	3.92%1.08B	6.58%1.06B	2.53%1.04B	165.51%1.1B	164.02%1.04B	144.30%994.2M
Notes receivable and accounts receivable	44.06%56.26M	33.71%54.1M	-20.06%48.97M	9.18%45.17M	-18.61%39.05M	6.36%40.46M	87.82%61.26M	30.21%41.38M	41.27%47.99M	25.66%38.04M
-Notes receivable	-1.37%2.97M	-52.63%1.7M	-43.19%8.32M	10.27%9.41M	-16.33%3.01M	20.63%3.58M	227.35%14.65M	119.06%8.53M	--3.6M	--2.97M
-Accounts receivable	47.86%53.29M	42.10%52.4M	-12.78%40.65M	8.90%35.77M	-18.80%36.04M	5.15%36.87M	65.63%46.61M	17.79%32.84M	30.67%44.38M	15.84%35.07M
Other receivables (including interest and dividends)	36.56%1.34M	42.82%1.32M	-87.43%1.15M	-78.52%1.25M	33.42%979.82K	29.96%921.65K	1,262.95%9.17M	292.95%5.83M	146.54%734.37K	162.69%709.18K
-Other receivable	----	42.82%1.32M	----	----	----	29.96%921.65K	----	292.95%5.83M	----	162.69%709.18K
Advance payment	130.66%17.72M	187.48%23.63M	55.55%16.87M	16.78%7.32M	1.40%7.68M	2.24%8.22M	190.98%10.85M	106.57%6.27M	117.15%7.58M	273.77%8.04M
Inventories	-17.17%102.57M	-18.08%112.27M	-28.72%105.72M	-15.28%124.61M	6.92%123.83M	7.86%137.05M	32.79%148.31M	31.67%147.08M	16.63%115.81M	54.89%127.06M
Receivable financing	23.14%7.55M	-25.94%6.95M	-31.76%6.69M	56.45%8.87M	-26.05%6.13M	24.62%9.38M	3.29%9.81M	98.46%5.67M	76.94%8.29M	31.21%7.53M
Other current assets	-2.72%52.44M	-0.62%52.61M	-1.39%51.4M	104.88%3.17M	137.73%53.9M	155.80%52.94M	6,060.48%52.13M	-30.35%1.55M	1,297.85%22.67M	2,988.87%20.7M
Total current assets	0.68%1.32B	0.69%1.32B	-1.05%1.32B	1.42%1.33B	5.58%1.31B	9.39%1.31B	13.44%1.34B	130.49%1.31B	131.29%1.24B	126.53%1.2B
Non Current assets
Investment real estate	-40.71%456.2K	-40.17%466.45K	184.43%476.71K	185.24%486.96K	342.60%769.42K	340.60%779.67K	-6.93%167.6K	-6.81%170.72K	-6.70%173.84K	-6.59%176.96K
Fixed assets	----	-0.46%321.7M	----	----	----	13.69%323.2M	----	0.40%295.14M	----	63.39%284.27M
Constru in process	----	469.53%38.12M	----	----	----	-56.42%6.69M	----	17.23%17.07M	----	-64.08%15.36M
Intangible assets	7.59%48.45M	7.51%48.76M	72.63%46.4M	64.77%44.74M	64.31%45.03M	64.11%45.36M	-3.27%26.88M	21.14%27.15M	20.70%27.41M	21.36%27.64M
Goodwill	0.00%517.84K	0.00%517.84K	0.00%517.84K	0.00%517.84K	0.00%517.84K	0.00%517.84K	0.00%517.84K	0.00%517.84K	0.00%517.84K	0.00%517.84K
Deferred tax assets	-9.95%2.21M	-7.78%2.21M	-13.04%2.06M	4.46%1.97M	28.39%2.46M	40.16%2.4M	32.76%2.36M	15.19%1.89M	5.19%1.91M	-15.26%1.71M
Usufruct assets	-6.52%2.58M	-4.40%2.92M	-17.81%2.76M	-16.11%3.06M	-23.84%2.76M	10.05%3.06M	9.24%3.35M	8.58%3.65M	--3.62M	--2.78M
Other non current assets	-23.26%18.51M	-6.81%17.04M	72.29%17.13M	-0.01%8.95M	94.85%24.13M	6.24%18.29M	-13.22%9.94M	-25.52%8.95M	38.82%12.38M	-35.54%17.21M
Total non current assets	9.81%444.01M	7.86%431.74M	18.14%420.36M	15.68%410.14M	16.02%404.34M	14.48%400.29M	1.20%355.83M	1.68%354.54M	10.39%348.51M	30.02%349.66M
Total assets	2.84%1.76B	2.37%1.75B	2.99%1.74B	4.46%1.74B	7.87%1.71B	10.54%1.71B	10.63%1.69B	81.46%1.66B	86.47%1.59B	93.96%1.55B
Liabilities
Current liabilities
Notes payable and accounts payable	5.39%80.79M	6.18%99.4M	-13.30%82.34M	9.52%108.02M	-11.55%76.65M	11.40%93.62M	5.88%94.97M	-1.00%98.63M	39.01%86.66M	26.10%84.04M
-Accounts payable	5.39%80.79M	6.18%99.4M	-13.30%82.34M	9.52%108.02M	-11.55%76.65M	11.40%93.62M	5.88%94.97M	-1.00%98.63M	39.01%86.66M	26.10%84.04M
Contract liabilities	-37.76%33.9M	-36.48%39.74M	-27.20%41.7M	-34.25%44.87M	31.81%54.48M	48.50%62.56M	74.90%57.28M	66.74%68.25M	-15.62%41.33M	9.09%42.13M
Advance receipts	-8.86%445.32K	-8.67%456.15K	-0.50%466.97K	1.22%477.8K	2.93%488.62K	4.62%499.45K	-2.23%469.34K	-2.22%472.02K	--474.7K	--477.39K
Salaries payable	-12.13%15.38M	-20.08%12.26M	9.64%13.34M	11.60%18.4M	33.02%17.51M	44.61%15.34M	37.52%12.17M	13.93%16.49M	19.27%13.16M	14.04%10.61M
Taxs payable	8.77%6.54M	18.98%9M	58.68%9.55M	-7.93%6.22M	-38.09%6.02M	-6.68%7.56M	432.82%6.02M	430.97%6.76M	90.96%9.72M	19.00%8.1M
Other payable (including interest and dividends)	-1.95%15.36M	-8.02%15.09M	-0.95%15.17M	4.89%16.29M	10.13%15.66M	13.76%16.41M	-16.92%15.32M	11.01%15.53M	8.04%14.22M	5.99%14.42M
-Other payable	----	-8.02%15.09M	----	----	----	13.76%16.41M	----	11.01%15.53M	----	5.99%14.42M
Non current liabilities due within one year	202.37%1.78M	212.65%1.91M	181.22%1.79M	212.00%1.95M	-41.72%589.38K	-48.25%612.31K	-45.71%634.98K	-45.13%624.12K	--1.01M	--1.18M
Other current liabilities	-22.30%6.41M	-41.96%5.31M	-27.18%11.48M	-28.76%7.36M	34.56%8.25M	90.64%9.16M	214.93%15.76M	58.01%10.34M	19.27%6.13M	7.27%4.8M
Total current liabilities	-10.59%160.61M	-10.98%183.18M	-13.22%175.84M	-6.21%203.6M	4.01%179.64M	24.13%205.76M	28.64%202.62M	21.65%217.09M	18.50%172.7M	18.86%165.77M
Current liabilities
Deferred tax liabilities	----	----	----	----	--413.75K	--458.34K	----	----	----	----
Long term deferred income	-7.78%17.51M	-17.69%16.36M	-13.97%17.23M	-13.40%18.1M	-12.82%18.99M	-12.22%19.88M	-8.58%20.03M	-2.46%20.9M	-1.97%21.78M	-1.57%22.65M
Lease liabilities	-92.53%113.35K	-89.08%180.48K	----	----	-42.90%1.52M	-3.34%1.65M	-17.10%1.79M	-16.23%1.95M	--2.66M	--1.71M
Total non current liabilities	-15.75%17.63M	-24.77%16.55M	-21.01%17.23M	-20.78%18.1M	-14.39%20.92M	-9.71%21.99M	-9.35%21.81M	-3.81%22.85M	9.99%24.44M	5.86%24.36M
Total liabilities	-11.13%178.24M	-12.31%199.72M	-13.98%193.07M	-7.60%221.7M	1.73%200.56M	19.79%227.75M	23.60%224.44M	18.66%239.93M	17.37%197.14M	17.02%190.13M
Shareholders equity
Paid-in capital	0.00%64M	0.00%64M	0.00%64M	0.00%64M	0.00%64M	0.00%64M	0.00%64M	33.33%64M	33.33%64M	33.33%64M
Capital reserve funds	0.00%654.95M	0.00%654.95M	0.00%654.95M	0.00%654.95M	0.01%654.95M	0.01%654.95M	0.01%654.95M	856.73%654.95M	856.64%654.89M	856.64%654.89M
Surplus reserve funds	19.83%101.03M	19.83%101.03M	13.75%101.03M	19.83%101.03M	19.63%84.31M	19.63%84.31M	26.02%88.82M	19.63%84.31M	26.79%70.48M	26.79%70.48M
Retained profit	13.02%801.4M	13.25%767.71M	16.47%767.59M	18.41%732.74M	17.90%709.1M	19.67%677.86M	18.14%659.07M	17.47%618.79M	17.56%601.43M	22.47%566.45M
Less:Treasury stock	--38.09M	--38.09M	--38.86M	--38.25M	----	----	----	----	----	----
Shareholders equity without minority interests	4.69%1.58B	4.62%1.55B	5.58%1.55B	6.50%1.51B	8.74%1.51B	9.24%1.48B	8.88%1.47B	99.25%1.42B	103.44%1.39B	113.66%1.36B
Total shareholder equity	4.69%1.58B	4.62%1.55B	5.58%1.55B	6.50%1.51B	8.74%1.51B	9.24%1.48B	8.88%1.47B	99.25%1.42B	103.44%1.39B	113.66%1.36B
Total liabilityies and equity	2.84%1.76B	2.37%1.75B	2.99%1.74B	4.46%1.74B	7.87%1.71B	10.54%1.71B	10.63%1.69B	81.46%1.66B	86.47%1.59B	93.96%1.55B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Rong Cheng Certified Public Accountants (Special General Partnership)	--	--	--	Rong Cheng Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

603102 Weihai Baihe Biology Technological

Weihai Baihe Biology Technological Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target